January 06, 2025 02:20 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 08:05 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 05:15 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

India commits to ship Covishield vaccines to Canada within a month

India commits to ship Covishield vaccines to Canada within a month

Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

Sep 10, 2020, at 11:14 pm

New Delhi/IBNS: Serum Institute of India (SII) on Thursday paused the trial of Covid-19 vaccine a day after it was served a show-cause notice by the Drugs Controller General of India (DCGI) for not informing the central drug regulator about the pause of study testing in other countries, media reports said.